AwesomeCapital
Thursday, May 30, 2019
Epizyme Submits NDA to FDA for Treatment of Epithelioid Sarcoma
https://www.streetinsider.com/Corporate+News/Epizyme+%28EPZM%29+Submits+NDA+to+FDA+for+Tazemetostat+for+Treatment+of+Patients+with+Epithelioid+Sarcoma/15557878.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.